Based on their pathological reports of ERBB2+ GC, all of those are intestinal-type GC in traditional Lauren classification, such as tubular adenocarcinoma, papillary adenocarcinoma, and a few mucinous adenocarcinomas. This evidence concerns the gene ERBB2 and gastric cancer.